| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6817550 | Psychoneuroendocrinology | 2018 | 25 Pages |
Abstract
Measuring inflammatory markers and targeting inflammation or its downstream mediators may be relevant for depressed patients with multiple failed antidepressant treatment trials in their current depressive episode.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ebrahim Haroon, Alexander W. Daguanno, Bobbi J. Woolwine, David R. Goldsmith, Wendy M. Baer, Evanthia C. Wommack, Jennifer C. Felger, Andrew H. Miller,